ONCT:US
$0.527
-
0.00%

Oncternal Therapeutics Inc.
News & Events

Last updated: Nov 5, 2025, 5:30 AM ET

  1. Oncternal Therapeutics Announces the Sale of Select Development Programs and the Wind-Down of its Operations

    GlobeNewswire JUL 1, 2025 8:00 AM EDT
    SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. today announced the sal...
    Read Article
  2. Oncternal Therapeutics Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC

    GlobeNewswire MAR 7, 2025 4:05 PM EST
    SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT) (the &#...
    Read Article
  3. Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments

    Canada Newswire SEP 22, 2020 7:00 AM EDT
    Milestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments ...
    Read Article
  4. Equities on the Move - Research on GTX Inc, Juniper Pharmaceuticals, Catabasis Pharmaceuticals and Amber Road

    ACCESS Newswire DEC 1, 2015 9:05 AM EST
    NEW YORK, NY / ACCESSWIRE / December 1, 2015 / Moments ago, Trader's Choice released new res...
    Read Article

Upcoming Events

Get notified of Oncternal Therapeutics Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available